Yash Flora

Performed medical monitoring and safety review for clinical trials, evaluating patient data, laboratory results, adverse events, and protocol deviations in compliance with ICH-GCP, FDA, and regulatory guidelines. Collaborated with investigators, CRAs, pharmacovigilance, and cross-functional clinical operations teams to ensure protocol compliance, patient safety oversight, risk management, and audi

Evaluated and ranked AI-generated scientific content for factual accuracy, reasoning quality, instruction adherence, and scientific rigor across biology and biomedical science domains. Developed and refined prompts to assess LLM performance, conducted domain-specific evaluations, annotation, response comparison, quality assurance reviews, and benchmarking tasks to support AI model improvement.

Developed a novel pexophagy reporter system to monitor peroxisome dynamics in vivo, demonstrating that PRX-11 inhibition improves mitochondrial function and extends lifespan by 20%. Conducted RNAi screening, RNA sequencing, and pathway analysis to identify genetic regulators and novel targets for age-related metabolic therapies. Elucidated SPIN-4's role in sperm activation through S1P efflux, engi

Analyzed molecular biomarker panels in over 1,000 blood samples using proprietary HrC blood test, achieving 99% accuracy in early-stage cancer risk profiling. Validated cancer stem cell marker expression via RT-PCR and flow cytometry, optimizing protocols to enhance detection sensitivity by 20% for diagnostic applications.

Identified and characterized Very Small Embryonic-like Stem Cells (VSELs) and Cardiac Stem Cells (CSCs), advancing understanding of cardiac regenerative potential. Optimized enzymatic digestion and centrifugation protocols, improving stem cell yield by 25% and purity by 30%, and developed RT-PCR and immunolabeling assays to detect pluripotency markers.

Isolated and characterized Lactobacillus strains from indigenous cattle, identifying two novel strains with high probiotic potential. Optimized in vitro assays to evaluate acid, bile, and salt tolerance, confirming 90% strain survivability and 75% inhibition of pathogenic bacteria, and conducted 16S rRNA gene sequencing and BLAST analysis for species identification.

Grade: 3.97/4.0

Doctor of Philosophy in Biology, graduated in August 2025 with a GPA of 3.97/4.0.

Grade: 9.21/10

Bachelor of Technology and Master of Technology in Biotechnology, graduated in May 2020 with a GPA of 9.21/10 and awarded Silver Medalist.